D-1500-2014 Class II Terminated
FDA drug recall D-1500-2014 was initiated by Jubilant Cadista Pharmaceuticals Inc. on Jul 11, 2014 and is designated Class II. Reason for recall: Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel. The recall status is terminated (terminated Sep 15, 2016). Affected quantity: 9,358 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 6, 2014
- Initiation Date
- Jul 11, 2014
- Termination Date
- Sep 15, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,358 bottles
Product Description
Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90
Reason for Recall
Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Distribution Pattern
Nationwide and Puerto Rico
Code Information
Lot #14P0292, Exp 04/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1500-2014
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026